Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan
Sponsored by Ipsen Biopharmaceuticals, Inc · EIN 260042539 · Plan #001
- Total assets
- $206M
- Net assets
- $206M
- Active participants
- 683
- With balances
- 1,193
Plan year beginning 01/01/2024 · 401(k)
Linked investment advisers
Advisory firms matched from Schedule C service providers (investment codes 26-28).
No linked investment advisers.
Service providers
Schedule C providers paid $5,000+ (large plans only).
| Provider | Services | Direct comp |
|---|---|---|
| Fidelity Investments Institutional | Participant loan processing, Sub-transfer agency fees, Recordkeeping fees | $65,648 |
| Moss Adams Llp | Accounting | $28,250 |